Diverse perspectives on science and medicine
Just a quick post today, because I wasn’t meaning to write here today but these two headlines jumped out and screamed to be linked to. First, there’s this one, from Reuters, an impressively lengthy article
From time to time, I look at her remnants – the belts hanging in the closet, framed pictures of her with her children when they were still young, jewelry, notes in the back of old
I’d mentioned several weeks ago about wanting to dig into the reported shortage of drugs for cancer and other diseases, but have been putting it off because I had nothing more to offer beyond pre-digested
The European Multidisciplinary Cancer Congress is the gift that keeps on giving. It’s with an almost predictable rhythm these days that articles either praising the promise of personalized medicine (that is, medical treatment tailored to
Yesterday, the Oncologic Drugs Advisory Committee issued its recommendation to the FDA on the use of Avastin for the treatment of breast cancer: no. Based on clinical trial results, ODAC members voted unanimously that the
Here is a current story that illustrates some of the major conundrums of modern drug development and health care. For those who are familiar with this little tale-in-progress, my guess is that you are, like